Drug Plan Management, Prescription Drugs Canadian Insurer details on coverage for Wegovy for cardiovascular treatment February 1, 2025 GroupForce Benefit News January 2025 Tags: Canada, Cardiovascular indication, Insurance, semaglutide, Wegovy, weight loss What do you think? Show comments / Leave a comment Insights More Related Articles The Workplace Verbal Offer, Offer Letters and Employment Agreements Dental Canadian Dental Care Program Resource Kit Uncategorized Increasing Employee Assistance (EAP) Usage
